InvestorsHub Logo

surf1944

02/29/12 12:12 PM

#103 RE: surf1944 #101

7:19AM Dyax appoints Dr. Burt Adelman as Chief Medical Officer (DYAX) 1.48 : Dr. Adelman will lead the development and regulatory strategy for the co's non-histamine-mediated angioedema franchise.